Evidence map›Paper›PMID 30219096›Full record

ArticleBiological research2018

Attenuation of atherogenic apo B-48-dependent hyperlipidemia and high density lipoprotein remodeling induced by vitamin C and E combination and their beneficial effect on lethal ischemic heart disease in mice.

S Contreras-Duarte, P Chen, M Andía, S Uribe, P Irarrázaval, S Kopp, S Kern, G Marsche, D Busso, C Wadsack and 1 more

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Biological research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. SR-B1-/-ApoE-R61h/h Mice Mimic Human Coronary Heart Disease.Cardiovascular drugs and therapy · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

S Contreras-DuarteDepartment of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Diagonal Paraguay #362 - 4º, Piso, 8330024, Santiago, Chile.
P ChenDepartment of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Diagonal Paraguay #362 - 4º, Piso, 8330024, Santiago, Chile.
M AndíaDepartment of Radiology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
S UribeDepartment of Radiology, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
P IrarrázavalBiomedical Imaging Center, School of Engineering, Pontificia Universidad Católica de Chile, Santiago, Chile.
S KoppDepartment of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
S KernInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
G MarscheInstitute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
D BussoDepartment of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Diagonal Paraguay #362 - 4º, Piso, 8330024, Santiago, Chile.
C WadsackDepartment of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria.
A RigottiDepartment of Nutrition, Diabetes and Metabolism, School of Medicine, Pontificia Universidad Católica de Chile, Diagonal Paraguay #362 - 4º, Piso, 8330024, Santiago, Chile. arigotti@med.puc.cl.
Pontificia Universidad Católica de Chile · CLMedical University of Graz · AT

Funding

Fondo Nacional de Desarrollo Científico y Tecnológico 1110712-1150399Fondo Nacional de Desarrollo Científico y Tecnológico 1141236Fondo Nacional de Desarrollo Científico y Tecnológico 21120282Fondo Nacional de Desarrollo Científico y Tecnológico ACT1416Österreichische Forschungsförderungsgesellschaft 4354192
6 · The paper itself

Abstract

BACKGROUND AND

aimsAtherosclerotic cardiovascular disease is highly prevalent and its underlying pathogenesis involves dyslipidemia including pro-atherogenic high density lipoprotein (HDL) remodeling. Vitamins C and E have been proposed as atheroprotective agents for cardiovascular disease management. However, their effects and benefits on high density lipoprotein function and remodeling are unknown. In this study, we evaluated the role of vitamin C and E on non HDL lipoproteins as well as HDL function and remodeling, along with their effects on inflammation/oxidation biomarkers and atherosclerosis in atherogenic diet-fed SR-B1 KO/ApoER61 METHODS AND

resultsMice were pre-treated for 5 weeks before and during atherogenic diet feeding with vitamin C and E added to water and diet, respectively. Compared to a control group, combined vitamin C and E administration reduced serum total cholesterol and triglyceride levels by decreasing apo B-48-containing lipoproteins, remodeled HDL particles by reducing phospholipid as well as increasing PON1 and apo D content, and diminished PLTP activity and levels. Vitamin supplementation improved HDL antioxidant function and lowered serum TNF-α levels. Vitamin C and E combination attenuated atherogenesis and increased lifespan in atherogenic diet-fed SR-B1 KO/ApoER61

conclusionsVitamin C and E administration showed significant lipid metabolism regulating effects, including HDL remodeling and decreased levels of apoB-containing lipoproteins, in mice. In addition, this vitamin supplementation generated a cardioprotective effect in a murine model of severe and lethal atherosclerotic ischemic heart disease.

Indexed as

AnimalsAntioxidantsApolipoprotein B-48Ascorbic AcidCardiotonic AgentsCoronary Artery DiseaseCytokinesDietary SupplementsDiet, AtherogenicEnzyme-Linked Immunosorbent AssayFemaleHyperlipidemiasImmunoblottingLipid MetabolismLipoproteins, HDLMaleAntioxidantsApolipoprotein B-48Ascorbic AcidCardiotonic AgentsCytokinesLipoproteins, HDLPhospholipid Transfer ProteinsScarb1 protein, mouseScavenger Receptors, Class BVitamin EAtherosclerosisHDLSerum lipidsVitamin C and E

Identifiers

PMID30219096
PMCPMC6138920
OpenAlexW2891782332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.